New viral and immun biomarkers are a powerful tool in the clinical management of patients with EBV-positive lymphomas

New viral and immun biomarkers are a powerful tool in the clinical management of patients with EBV-positive lymphomas [ 2007 - 2011 ]

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/443028]

Researchers: Prof Maher Gandhi (Principal investigator)

Funding Amount $AUD 471,058.72

Funding Scheme Career Development Fellowships

Notes Clinical CDF

Click to explore relationships graph

Subjects

Identifiers